|
Fusion gene ID: 34024 |
FusionGeneSummary for SLC12A2_C5orf58 |
Fusion gene summary |
Fusion gene information | Fusion gene name: SLC12A2_C5orf58 | Fusion gene ID: 34024 | Hgene | Tgene | Gene symbol | SLC12A2 | C5orf58 | Gene ID | 6558 | 133874 |
Gene name | solute carrier family 12 member 2 | chromosome 5 open reading frame 58 | |
Synonyms | BSC|BSC2|NKCC1|PPP1R141 | - | |
Cytomap | 5q23.3 | 5q35.1 | |
Type of gene | protein-coding | protein-coding | |
Description | solute carrier family 12 member 2basolateral Na-K-Cl symporterbumetanide-sensitive sodium-(potassium)-chloride cotransporter 1protein phosphatase 1, regulatory subunit 141solute carrier family 12 (sodium/potassium/chloride transporter), member 2solut | putative uncharacterized protein C5orf58 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | P55011 | C9J3I9 | |
Ensembl transtripts involved in fusion gene | ENST00000262461, ENST00000343225, ENST00000507791, | ENST00000521850, ENST00000517575, ENST00000593851, | |
Fusion gene scores | * DoF score | 9 X 6 X 4=216 | 3 X 3 X 3=27 |
# samples | 9 | 3 | |
** MAII score | log2(9/216*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: SLC12A2 [Title/Abstract] AND C5orf58 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | SLC12A2 | GO:0015696 | ammonium transport | 12946942|18032481 |
Hgene | SLC12A2 | GO:0030321 | transepithelial chloride transport | 12946942 |
Hgene | SLC12A2 | GO:0070634 | transepithelial ammonium transport | 18032481 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | COAD | TCGA-CM-6170-01A | SLC12A2 | chr5 | 127524015 | + | C5orf58 | chr5 | 169660264 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-5UTR | ENST00000262461 | ENST00000521850 | SLC12A2 | chr5 | 127524015 | + | C5orf58 | chr5 | 169660264 | + |
3UTR-intron | ENST00000262461 | ENST00000517575 | SLC12A2 | chr5 | 127524015 | + | C5orf58 | chr5 | 169660264 | + |
3UTR-intron | ENST00000262461 | ENST00000593851 | SLC12A2 | chr5 | 127524015 | + | C5orf58 | chr5 | 169660264 | + |
3UTR-5UTR | ENST00000343225 | ENST00000521850 | SLC12A2 | chr5 | 127524015 | + | C5orf58 | chr5 | 169660264 | + |
3UTR-intron | ENST00000343225 | ENST00000517575 | SLC12A2 | chr5 | 127524015 | + | C5orf58 | chr5 | 169660264 | + |
3UTR-intron | ENST00000343225 | ENST00000593851 | SLC12A2 | chr5 | 127524015 | + | C5orf58 | chr5 | 169660264 | + |
intron-5UTR | ENST00000507791 | ENST00000521850 | SLC12A2 | chr5 | 127524015 | + | C5orf58 | chr5 | 169660264 | + |
intron-intron | ENST00000507791 | ENST00000517575 | SLC12A2 | chr5 | 127524015 | + | C5orf58 | chr5 | 169660264 | + |
intron-intron | ENST00000507791 | ENST00000593851 | SLC12A2 | chr5 | 127524015 | + | C5orf58 | chr5 | 169660264 | + |
Top |
FusionProtFeatures for SLC12A2_C5orf58 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
SLC12A2 | C5orf58 |
Electrically silent transporter system. Mediates sodiumand chloride reabsorption. Plays a vital role in the regulation ofionic balance and cell volume. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SLC12A2_C5orf58 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SLC12A2_C5orf58 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
SLC12A2 | STK39, MAPK14, SLC12A2, SEC13, COMMD1, ATP4A, EGFR, CUL7, CCDC8, ILK, LGALS3, LGALS8, MCOLN3, LGALS9, LGALS9C, FAM189A2, ZACN, NTRK1, GNG12, TCTN3, TMEM17, TMEM216, AK1, CDKN2AIP, CDH1, CTDSPL, PTGIR, HTR3A, TMED6 | C5orf58 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SLC12A2_C5orf58 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | SLC12A2 | P55011 | DB00887 | Bumetanide | Solute carrier family 12 member 2 | small molecule | approved |
Hgene | SLC12A2 | P55011 | DB01325 | Quinethazone | Solute carrier family 12 member 2 | small molecule | approved |
Hgene | SLC12A2 | P55011 | DB00761 | Potassium Chloride | Solute carrier family 12 member 2 | small molecule | approved|withdrawn |
Top |
RelatedDiseases for SLC12A2_C5orf58 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SLC12A2 | C0036341 | Schizophrenia | 4 | PSYGENET |
Hgene | SLC12A2 | C0007222 | Cardiovascular Diseases | 1 | CTD_human |
Hgene | SLC12A2 | C0014544 | Epilepsy | 1 | CTD_human |
Hgene | SLC12A2 | C0014556 | Epilepsy, Temporal Lobe | 1 | CTD_human |
Hgene | SLC12A2 | C0020538 | Hypertensive disease | 1 | CTD_human |
Hgene | SLC12A2 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Hgene | SLC12A2 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Hgene | SLC12A2 | C0026650 | Movement Disorders | 1 | CTD_human |
Hgene | SLC12A2 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | SLC12A2 | C0033975 | Psychotic Disorders | 1 | PSYGENET |
Hgene | SLC12A2 | C0271650 | Impaired glucose tolerance | 1 | CTD_human |